Venous thromboembolism prophylaxis for surgical patients in an Asian hospital

ANZ Journal of Surgery

Volumn 74, Issue 6, 2004, Pages 455-459

  Tan, Li Hoon ^a   Tan, Shwu Chuin ^a  

^a CHANGI GENERAL HOSPITAL   (Singapore)

Author keywords

Asian; Deep vein thrombosis; Prophylaxis; Pulmonary embolism; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ELECTIVE SURGERY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; ORTHOPEDIC SURGERY; PERIOPERATIVE PERIOD; PROSPECTIVE STUDY; SURGICAL RISK; VENOUS THROMBOEMBOLISM;

ADULT; FEMALE; FIBRINOLYTIC AGENTS; HOSPITALS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SINGAPORE; THROMBOEMBOLISM;

EID: 3042714527     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-1433.2004.03025.x     Document Type: Article

References (28)

1. White R, Zhou H, Romano P. Incidence of idiopathic deep vein thrombosis and secondary thromboembolism among ethnic groups in California. Ann. Intern. Med. 1998; 128: 737-40.
2. Tan SM, Ng KS. Pulmonary embolism in an Asian surgical intensive care unit: a series of 4 cases and a review of the practice of prophylaxis. Crit. Care Shock 2001; 4: 211-16.
3. Kum CK, Sim EKW, Ngoi SS. Deep vein thrombosis complicating colorectal surgery in the Chinese in Singapore. Ann. Acad. Med. Singapore 1993; 22: 895-7.
4. Dhillon KS, Askander A, Doraisamy S. Postoperative deep-vein thrombosis in Asian patients is not a rarity. A prospective study of 88 patients with no prophylaxis. J. Bone Joint Surg. 1996; 78-B: 427-30.
5. Nandi PL, Li WS, Leung R, Chan J, Chan HT. Deep vein thrombosis and pulmonary embolism in the Chinese population. Hong Kong Med. J. 1998; 4: 305-10.
6. Lee HM, Suk KS, Moon SH, Lim DJ, Wang JMJ, Kim NH. Deep vein thrombosis after major spinal surgery. Incidence in an East Asian population. Spine 2000; 25: 1827-30.
7. Lee FY, Chu W, Chan R et al. Incidence of deep vein thrombosis after colorectal surgery in a Chinese population. ANZ J. Surg. 2001; 71: 637-40.
8. Geerts WH, Heit JA, Clagett GP et al. Prevention of venous thromboembolism. Chest 2001; 119: 132S-75S.
9. Arnold DM, Kahn SR, Shrier I. Missed opportunities for prevention of venous thromboembolism. An evaluation of the use of thromboprophylaxis guidelines. Chest 2001; 120: 1964-71.
10. Lepaux DJ, Charpentier C, Pertek JP et al. Assessment of deep vein thrombosis prophylaxis in surgical patients: a study conducted at Nancy University Hospital, France. Eur. J. Clin. Pharmocol. 1998; 54: 671-6.
11. Ahmad HA, Geissler A, Maclellan DG. Deep vein thrombosis prophylaxis: are guidelines being followed? ANZ J. Surg. 2002; 72: 331-4.
12. Gillies TA, Ruckley CV, Nixon SJ. Still missing the boat with fatal pulmonary embolism. Br. J. Surg. 1996; 83: 1394-5.
13. George BD, Nethercliff J, Cook TA, Galland RB, Franklin IJ. Protocol violation in deep vein thrombosis prophylaxis. Ann. R. Coll. Surg. Engl. 1998; 80: 55-7.
14. Bratzler DW, Raskob GE, Murray CK, Bumpus LJ, Piatt DS. Underuse of venous thromboembolism prophylaxis for general surgery patients. Arch. Intern. Med. 1998; 158: 1909-12.
15. Stratton MA, Anderson FA, Bussey HI et al. Prevention of venous thromboembolism. Adherence to the 1995 American College of Chest Physicians consensus guidelines for surgical patients. Arch. Intern. Med. 2000; 160: 334-40.
16. Williams HR, MacDonald DA. Audit of thromboembolic prophylaxis in hip and knee surgery. Ann. R. Coll. Surg. Engl. 1997; 79: 55-7.
17. Thromboembolic Risk Factors (THRIFT) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ. 1992; 305: 567-74.
18. Altman DG, Machin D, Bryant TN, Gardner MJ (eds). Statistics with Confidence: Confidence Intervals and Statistical Guidelines, 2nd edn. London: BMJ Publishing Groups, 2000.
19. Lee LH, Gu KQ, Heng D. Deep vein thrombosis is not rare in Asia - the Singapore General Hospital experience. Ann. Acad. Med. Singapore 2002; 31: 761-4.
20. Lee LH. Clinical update on deep vein thrombosis in Singapore. Ann. Acad. Med. Singapore 2002; 31: 248-52.
21. Price DT, Ridker PM. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Ann. Intern. Med. 1997; 127: 895-903.
22. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of Factor V Leiden in 4047 men and women: implications for venous thromboembolism screening. JAMA 1997; 277: 1305-7.
23. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4.
24. Ho YH, Seow-Choen F, Leong A, Eu KW, Nyam D, Teoh MK. Randomized, controlled trial of low molecular weight heparin vs. no deep vein thrombosis prophylaxis for major colon and rectal surgery in Asian patients. Dis. Colon Rectum 1999; 42: 196-203.
25. Fong YK, Ruban P, Lee BPH, Lo NN, Seow KH, Ng SCK. Use of low molecular weight heparin for prevention of deep vein thrombosis in total knee arthroplasty - a study of its efficacy in an Asian population. Ann. Acad. Med. Singapore 2000; 29: 439-41.
26. Yoo MC, Kang CS, Kim YH, Kim SK. A prospective randomized study on the use of nadroparin calcium in the prophylaxis of thromboembolism in Korean patients undergoing elective total hip replacement. Int. Orthop. 1997; 21: 399-402.
27. Levine MN, Raskob G, Landefeld S, Kearon C. Hemorrhagic complications of anticoagulant treatment. Chest 2001; 119: 108S-21S.
28. Lumpkin MM. FDA Public Health Advisory. Anesthesiology 1998; 88: 27A-8A.